Abstract
VTD (Bortezomib/Thalidomide/Dexamethasone) As Pretransplant Induction Therapy for Multiple Myeloma: Definitive Results of a Randomized Phase 3 Pethema/GEM Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have